Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Total Debt (2022 - 2025)

Envoy Medical's Total Debt history spans 4 years, with the latest figure at $9.3 million for Q2 2025.

  • For Q2 2025, Total Debt rose 272.0% year-over-year to $9.3 million; the TTM value through Jun 2025 reached $9.3 million, up 272.0%, while the annual FY2024 figure was $18.7 million, 5918.01% up from the prior year.
  • Total Debt for Q2 2025 was $9.3 million at Envoy Medical, down from $23.1 million in the prior quarter.
  • Across five years, Total Debt topped out at $23.1 million in Q1 2025 and bottomed at $228000.0 in Q3 2023.
  • The 4-year median for Total Debt is $5.9 million (2024), against an average of $8.6 million.
  • The largest annual shift saw Total Debt fell 7.16% in 2023 before it soared 6196.49% in 2024.
  • A 4-year view of Total Debt shows it stood at $335000.0 in 2022, then dropped by 7.16% to $311000.0 in 2023, then soared by 5918.01% to $18.7 million in 2024, then plummeted by 50.31% to $9.3 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Total Debt are $9.3 million (Q2 2025), $23.1 million (Q1 2025), and $18.7 million (Q4 2024).